Antithyroid Drug-induced Agranulocytosis

Journal of the Chinese Medical Association

Volumn 72, Issue 8, 2009, Pages 438-441

  Sun, Ming Tsung ^a,c   Tsai, Chen Hao ^b,c   Shih, Kuang Chung ^c  

^a HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

agranulocytosis; antithyroid drugs; methimazole; propylthiouracil; thioamide

Indexed keywords

ANTIBIOTIC AGENT; ANTITHYROID AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; BLOOD CELL COUNT; CAREGIVER; CASE REPORT; DRUG DOSE INCREASE; FEMALE; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LEUKOCYTE COUNT; PATIENT EDUCATION; PROGNOSIS; STAPHYLOCOCCUS AUREUS; SYMPTOMATOLOGY; THROAT CULTURE; THYROID SCINTISCANNING; TREATMENT RESPONSE;

ADULT; AGED; AGRANULOCYTOSIS; ANTITHYROID AGENTS; FEMALE; HUMANS; MIDDLE AGED;

EID: 70449331511     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70402-2     Document Type: Article

References (14)

1. Cooper D.S. Antithyroid drugs. N Engl J Med 311 (1984) 1353-1362
2. McClung M.R., and Greer M.A. Treatment of hyperthyroidism. Annu Rev Med 31 (1980) 385-404
3. Tajiri J., Noguchi S., Murakami T., and Murakami N. Antithyroid drug-induced agranulocytosis: the usefulness of routine white blood cell count monitoring. Arch Intern Med 150 (1990) 621-624
4. Bartalena L., Bogazzi F., and Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Safety 15 (1996) 53-63
5. Thomas D., Moisidis A., Tsiakalos A., Alexandraki K., Syriou V., and Kaltsas G. Antithyroid drug-induced aplastic anemia. Thyroid 18 (2008) 1043-1048
6. Pearce S.H. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 61 (2004) 589-594
7. Cooper D.S., Goldminz D., Levin A.A., Ladenson P.W., Daniels G.H., Molitch M.E., and Ridgway E.C. Agranulocytosis associated with antithyroid drugs: effects of patient age and drug dose. Ann Intern Med 98 (1983) 26-29
8. Tamai H., Takaichi Y., Morita T., Komaki G., Matsubayashi S., Kuma K., Walter Jr. R.M., et al. Methimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clin Endocrinol (Oxf) 30 (1989) 525-530
9. Meyer-Gessner M., Benker G., Lederbogen S., Olbricht T., and Reinwein D. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 17 (1994) 29-36
10. Werner M.C., Romaldini J.H., Bromberg N., Werner R.S., and Farah C.S. Adverse effects related to thioamide drugs and their dose regimen. Am J Med Sci 297 (1989) 216-219
11. Wall J.R., Fang S.L., Kuroki T., Ingbar S.H., and Braverman L.E. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 58 (1984) 868-872
12. Biswas N., Ahn Y.H., Goldman J.M., and Schwartz J.M. Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301 (1991) 190-194
13. Andersohn F., Konzen C., and Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146 (2007) 657-665
14. Tamai H., Mukuta T., Matsubayashi S., Fukata S., Komaki G., Kuma K., Kumagai L.F., et al. Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor (rhG-CSF). J Clin Endocrinol Metab 77 (1993) 1356-1360